Compare RGR & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGR | THW |
|---|---|---|
| Founded | 1949 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Finance Companies |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 521.9M | 513.9M |
| IPO Year | 1994 | 2015 |
| Metric | RGR | THW |
|---|---|---|
| Price | $41.71 | $12.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $43.00 | N/A |
| AVG Volume (30 Days) | ★ 160.0K | 82.9K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.09% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $546,057,000.00 | N/A |
| Revenue This Year | $2.38 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.94 | N/A |
| 52 Week Low | $28.33 | $10.10 |
| 52 Week High | $48.21 | $13.19 |
| Indicator | RGR | THW |
|---|---|---|
| Relative Strength Index (RSI) | 57.89 | 61.53 |
| Support Level | $36.28 | $12.33 |
| Resistance Level | $44.10 | $12.95 |
| Average True Range (ATR) | 1.16 | 0.28 |
| MACD | 0.02 | 0.13 |
| Stochastic Oscillator | 73.84 | 90.06 |
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.